GlobeImmune's Convertible Note - II Round

GlobeImmune raised a round of funding on March 12, 2014.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Convertible Note - II Round: